Streetbeat News

Stock Prices

KULR

KULR Technology Group shares are trading lower after the company announced worse-than-expected Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:48 am

GM

General Motors (GM) is seeking a level playing field against Chinese EV makers, as stated by President Mark Reuss. The company is concerned about China's pricing strategies and the impact on local players. The Biden administration has increased tariffs on Chinese EVs, further restricting their entry into the U.S. market. GM's EV sales dropped 20.5% year-on-year in Q1 2024, largely due to the discontinuation of the Chevrolet Bolt. GM recently launched the Chevrolet Equinox EV, aiming to compete with Tesla's Model Y.

Portfolio Pulse from Anan Ashraf

May 16, 2024 | 11:48 am

TSRI

TSR shares are trading higher following the announcement of a definitive agreement to be acquired by Vienna Parent.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:46 am

WMT

Walmart Inc (NYSE:WMT) reported strong Q1 2025 earnings, beating revenue and EPS expectations. The company saw significant growth in revenue, operating income, and eCommerce sales, and raised its outlook for the fiscal year.

Portfolio Pulse from Vandana Singh

May 16, 2024 | 11:45 am

CARM

Carisma Therapeutics has dosed the first patient in a Phase 1 clinical trial of CT-0525, a novel HER2-targeting CAR-Monocyte. This is the first CAR-Monocyte to be evaluated in humans for solid tumors, with initial data expected by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:43 am

JDZG

JIADE shares are experiencing increased trading activity and higher prices amid post-IPO volatility.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:42 am

TRUP

Trupanion shares are trading higher after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $35 to $49.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:41 am

BIIB

IONS

Ionis Pharmaceuticals and Biogen have announced the discontinuation of the development of BIIB105 based on data from a Phase 1/2 study.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:36 am

UA

UAA

Under Armour shares are trading lower after the company issued weak FY25 guidance.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:33 am

MTNB

Matinas BioPharma presented new in vitro data at TIDES USA 2024, demonstrating their LNC platform's ability to deliver small oligonucleotides.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:32 am